Imported-post
-
Discovery Vanderbilt invests in two engineering faculty-initiated startups: HeroWear and Virtuoso
A university leadership committee has approved Discovery Vanderbilt investments into three faculty-initiated startups—HeroWear, IDBiologics and Virtuoso Surgical Inc.—as part of its mission from the offices of the chancellor and provost to boost innovation across the university. “These three initial investments will fuel discovery and accelerate the translation of our research into real-world benefits,” Chancellor Daniel... Read MoreMay 29, 2023
-
Steed chosen to direct Family Nurse Practitioner program
Julia Steed will become academic director of the Vanderbilt University School of Nursing Family Nurse Practitioner Program. She replaces Courtney Pitts who led the top-ranked specialty for the past seven years. Read MoreMay 25, 2023
-
RESEARCH SPOTLIGHT: Nuclear fusion and the future of clean energy
History was made in December when scientists at Lawrence Livermore National Laboratory’s National Ignition Facility successfully produced a nuclear fusion reaction resulting in a net energy gain. And a Washington-based start-up backed by hundreds of millions of dollars of venture capital announced a few months later that it expects to have a fusion power plant built... Read MoreMay 25, 2023
-
Kennedy named Association of Women’s Health and Obstetrics Neonatal Nurses fellow
School of Nursing Professor and Associate Dean for Academic and Curriculum Affairs Betsy Kennedy, BSN’89, MSN’93, PhD, ANEF, has been named as an Association of Women’s Health and Obstetrics Neonatal Nurses fellow. Read MoreMay 24, 2023
-
New view of mutations informs disease risk, treatment response
A transcontinental research effort led by scientists from Vanderbilt University Medical Center and the University of Michigan has upended some long-standing assumptions about mutations — how often they occur, what causes them and what they do. Read MoreMay 18, 2023
-
Diabetes drugs associated with fewer adverse cardiac events in older veterans: study
Vanderbilt research finds that GLP1 receptor agonists — a class of diabetes medications — are associated with fewer major adverse cardiovascular events than another type of diabetes drug (DPP4 inhibitors) in older veterans with no prior heart disease. Read MoreMay 8, 2023
-
Tracking lung macrophages
A new technique will allow researchers to track subsets of immune cells that patrol and defend the lungs, to better understand the roles of these cells during lung inflammation, infection and injury. Read MoreMay 4, 2023
-
Better adenoma detection
Fluorescent nanoparticles clearly identified colonic adenomas — precursors to colorectal cancer — in mice, and the formulation should translate to clinical use in humans. Read MoreMay 4, 2023
-
Engineering student awarded extended DOE residency at Savannah River National Laboratory to continue doctoral research
Nicole Moehring, a fifth-year graduate student in interdisciplinary materials science, has been selected for an extended residency to continue her doctoral research at the Savannah River National Laboratory. She is one of just 87 awardees selected by the Department of Energy Office of Science Graduate Student Research program this year. Nicole Moehring (Anne Rayner) At... Read MoreMay 1, 2023
-
Study details RNA editing in virus-infected cancer cells
Vanderbilt researchers detail the landscape of RNA editing — a form of RNA modification — in primary effusion lymphoma cells during Kaposi’s sarcoma-associated herpesvirus infection and identify an edited viral microRNA that is critical for infection. Read MoreApril 20, 2023